Literature DB >> 6155174

Reduced dopaminergic binding during aging in the rodent striatum.

J A Severson, C E Finch.   

Abstract

[3H]Spiroperidol and [3H]ADTN ( 2-amino-l,7-dihydroxy-1,2,3,4-tetra hydronaphthalene) binding were used to assay for dopamine receptors in aged C57BL/6J mouse striatal membranes. [3H]spiroperidol binding declined linearly with age starting at 3 months. By 28 months, spiroperidol binding was only about 50% of the 3 month value. Dissociation constants dissociation rates and binding inhibition by (+)-butaclamol (antagonist) and apomorphine (agonist) were similar, suggesting that the age-related loss of spiroperidol binding was due to a loss in receptor number and not an alteration in binding affinity. [3H]ADTN binding also declined with age, but the losses tended to be about twice as large as those seen for spiroperidol. Consideration of possible mechanisms of receptor loss with age indicate that nigrostriatal denervation effects cannot explain all aging changes in striatal dopaminergic functions. The loss of receptors with age may derive from a loss of striatal neurones on which residue a population of dopaminergic binding sites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155174     DOI: 10.1016/0006-8993(80)91015-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases.

Authors:  Ben A Bahr; Meagan L Wisniewski; David Butler
Journal:  Rejuvenation Res       Date:  2012-04       Impact factor: 4.663

2.  Age-related changes in human D1 dopamine receptors measured by positron emission tomography.

Authors:  T Suhara; H Fukuda; O Inoue; T Itoh; K Suzuki; T Yamasaki; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway.

Authors:  Stephanie C Gantz; Christopher P Ford; Kim A Neve; John T Williams
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

Review 4.  Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging.

Authors:  Caleb E Finch; Steven N Austad
Journal:  Age (Dordr)       Date:  2012-01-05

5.  Decrease in the number of high-affinity opiate binding sites during the aging process in Mytilus edulis (Bivalvia).

Authors:  G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1981-12       Impact factor: 5.046

6.  Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats.

Authors:  P G MacRae; W W Spirduso; T J Walters; R P Farrar; R E Wilcox
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Stability of large cell-medium cell clusters in the mature neostriatum.

Authors:  P L Mensah
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

8.  Differential effects of apomorphine in 6-hydroxydopamine-treated and aged rats.

Authors:  M D Schechter; J T Concannon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Influence of dietary vitamin E, selenium and age on regional distribution of alpha-tocopherol in the rat brain.

Authors:  M Meydani; J B Macauley; J B Blumberg
Journal:  Lipids       Date:  1986-12       Impact factor: 1.880

10.  Age difference in apomorphine-induced stereotypy in rats: relationship to plasma and brain concentrations.

Authors:  H Watanabe; S Nakano; N Ogawa
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.